Search results for asxl2

197 hits were found for asxl2

# Family MCID Name MIFTS Score
1
SHS001 Shashi-Pena Syndrome 26 50.727
2
MYL009 Myelodysplastic Syndrome 67 14.665
3
c LKM061 Leukemia, Acute Myeloid 83 3.246
4
P MYL006 Myeloid Leukemia 60 2.832
5
P LKM002 Leukemia 66 2.262
6
BLD173 Bladder Small Cell Carcinoma 44 2.195
7
GST103 Gastric Cancer, Hereditary Diffuse 68 1.813
8
P BLD134 Bladder Cancer 79 1.795
9
BNB002 Bainbridge-Ropers Syndrome 45 1.743
10
END057 Endometrial Cancer 71 1.737
11
SML009 Small Intestine Adenocarcinoma 57 1.653
12
P PRS040 Prostate Cancer 95 1.596
13
P LNG064 Lung Cancer Susceptibility 3 70 1.524
14
P GST053 Gastric Cancer 82 1.507
15
c CLR087 Colorectal Cancer 12 34 1.491
16
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 60 1.491
17
P DBT009 Diabetes Mellitus 67 1.468
18
LNG039 Lung Squamous Cell Carcinoma 57 1.465
19
CLN015 Colon Adenocarcinoma 64 1.428
20
ADN011 Adenoid Cystic Carcinoma 68 1.411
21
GST040 Gastric Adenocarcinoma 66 1.411
22
P LNG032 Lung Cancer 98 1.410
23
NNL005 Non-Alcoholic Fatty Liver Disease 63 1.392
24
P HPT023 Hepatocellular Carcinoma 95 1.392
25
P CLR023 Colorectal Cancer 100 1.290
26
P TMR010 Tumor Predisposition Syndrome 69 1.255
27
ADN089 Adenosquamous Lung Carcinoma 49 1.255
28
BRN015 Bronchiolo-Alveolar Adenocarcinoma 55 1.255
29
BHR002 Bohring-Opitz Syndrome 48 1.224
30
c DLT002 Dilated Cardiomyopathy 79 1.224
31
P MSC005 Muscular Dystrophy 66 1.224
32
ESP021 Esophageal Cancer 84 1.188
33
P HYP265 Hypotonia 42 1.148
34
BNR002 Bone Resorption Disease 47 1.120
35
TRD008 Triiodothyronine Receptor Auxiliary Protein 33 1.120
36
CHL149 Childhood Acute Myeloid Leukemia 42 1.120
37
BP1002 Bap1 Tumor Predisposition Syndrome 42 1.120
38
GLB021 Global Developmental Delay, Absent or Hypoplastic Corpus Callosum, and Dysmorphic Facies 38 1.089
39
HYP748 Hypertelorism 46 1.089
40
ALC028 Alacrima, Achalasia, and Mental Retardation Syndrome 68 1.089
41
SPL018 Splenomegaly 47 1.089
42
P OVR082 Overgrowth Syndrome 42 1.089
43
P BDY004 Body Mass Index Quantitative Trait Locus 11 83 1.056
44
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 1.056
45
c BDY012 Body Mass Index Quantitative Trait Locus 7 43 1.056
46
ATH013 Atherosclerosis Susceptibility 63 1.056
47
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 1.056
48
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 1.056
49
P MYC007 Myocardial Infarction 69 1.056
50
c BDY006 Body Mass Index Quantitative Trait Locus 8 43 1.056
51
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 1.056
52
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 1.056
53
c BDY019 Body Mass Index Quantitative Trait Locus 18 47 1.056
54
c BDY020 Body Mass Index Quantitative Trait Locus 19 51 1.056
55
STR067 Stroke, Ischemic 79 1.056
56
c CHR684 Chronic Kidney Disease 74 1.056
57
P KDN018 Kidney Disease 72 1.056
58
c ACT075 Acute Myocardial Infarction 55 1.056
59
c MSM022 Mismatch Repair Cancer Syndrome 1 69 1.032
60
c GLM043 Glioma Susceptibility 9 30 1.032
61
c GLM047 Glioma Susceptibility 3 32 1.032
62
c GLM025 Glioma Susceptibility 2 29 1.032
63
P GLM040 Glioma Susceptibility 1 70 1.032
64
P OLG002 Oligodendroglioma 66 1.032
65
MNN043 Meningioma, Familial 79 1.032
66
GLM045 Glioma 62 1.032
67
NNL006 Non-Alcoholic Steatohepatitis 54 1.019
68
P BRS047 Breast Cancer 97 0.975
69
END041 Endometrial Adenocarcinoma 63 0.962
70
LNG111 Lung Non-Squamous Non-Small Cell Carcinoma 56 0.887
71
LNG019 Lung Combined Type Small Cell Carcinoma 32 0.887
72
P LNG021 Lung Occult Small Cell Carcinoma 20 0.887
73
HGH043 High Grade Glioma 46 0.864
74
c PRS070 Prostate Cancer, Hereditary, 12 22 0.834
75
c PRS071 Prostate Cancer, Hereditary, 13 25 0.834
76
c PRS117 Prostate Cancer, Hereditary, 11 24 0.834
77
c PRS114 Prostate Cancer, Hereditary, 2 33 0.834
78
c PRS097 Prostate Cancer, Hereditary, 1 38 0.834
79
BRS099 Breast Ductal Carcinoma 61 0.834
80
PRS015 Prostate Signet Ring Cell Adenocarcinoma 25 0.834
81
PPL004 Papillary Squamous Carcinoma 39 0.834
82
SQM013 Squamous Cell Carcinoma, Head and Neck 75 0.805
83
PLM173 Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and 46,xx Sex Reversal 34 0.776
84
SKN022 Skin Squamous Cell Carcinoma 54 0.776
85
PSD011 Pseudovascular Skin Squamous Cell Carcinoma 16 0.776
86
P BLD062 Bile Duct Cancer 68 0.646
87
PNS010 Penis Squamous Cell Carcinoma 45 0.609
88
PNS005 Penis Mixed Squamous Cell Carcinoma 12 0.609
89
P PNC035 Pancreatic Cancer 86 0.602
90
c BSL024 Basal Cell Carcinoma 1 54 0.527
91
c BSL034 Basal Cell Carcinoma 7 25 0.527
92
RMB001 Rombo Syndrome 29 0.527
93
BSL044 Basal Cell Carcinoma, Infundibulocystic 35 0.527
94
RNL114 Renal Cell Carcinoma, Nonpapillary 79 0.527
95
PGT003 Paget Disease, Extramammary 47 0.527
96
P TRC095 Trichoepithelioma, Multiple Familial, 1 32 0.527
97
P RTH006 Rothmund-Thomson Syndrome, Type 2 67 0.527
98
c BSL007 Basal Cell Carcinoma 68 0.527
99
SQM006 Squamous Cell Carcinoma 59 0.527
100
NDL009 Nodular Basal Cell Carcinoma 40 0.527
101
MTT001 Metatypical Basal Cell Carcinoma 31 0.527
102
PGM002 Pigmented Basal Cell Carcinoma 31 0.527
103
ANL013 Anal Margin Basal Cell Carcinoma 18 0.527
104
SBC013 Sebaceous Basal Cell Carcinoma 13 0.527
105
MCR016 Micronodular Basal Cell Carcinoma 34 0.527
106
ADM002 Adamantinoid Basal Cell Epithelioma 20 0.527
107
CLR015 Clear Cell Basal Cell Carcinoma 39 0.527
108
ADN015 Adenoid Basal Cell Carcinoma 31 0.527
109
MRK001 Merkel Cell Carcinoma 65 0.527
110
INF027 Infiltrative Basal Cell Carcinoma 32 0.527
111
CYS004 Cystic Basal Cell Carcinoma 36 0.527
112
SRC003 Sarcomatoid Basal Cell Carcinoma 28 0.527
113
SGN001 Signet Ring Basal Cell Carcinoma 32 0.527
114
INF057 Inflammatory Linear Verrucous Epidermal Nevus 33 0.527
115
9Q2001 9q22.3 Microdeletion 24 0.527
116
LNR004 Linear Porokeratosis 33 0.527
117
ORL011 Oral Cancer 60 0.527
118
THY121 Thyroid Gland Anaplastic Carcinoma 66 0.430
119
P BNG032 Benign Mesothelioma 53 0.381
120
IRN008 Iron Overload in Africa 51 0.373
121
RNL065 Renal Cell Carcinoma, Papillary, 1 79 0.373
122
RJS001 Ruijs-Aalfs Syndrome 47 0.373
123
P OVR042 Ovarian Cancer 88 0.373
124
VNH007 Von Hippel-Lindau Syndrome 73 0.373
125
P SLV026 Salivary Gland Carcinoma 60 0.373
126
HPT079 Hepatoid Adenocarcinoma 39 0.373
127
c CHL136 Cholestasis, Progressive Familial Intrahepatic, 2 57 0.373
128
c HPT073 Hepatitis C Virus 71 0.373
129
MYX005 Myxoid Liposarcoma 65 0.373
130
RNL119 Renal Cell Carcinoma, Xp11-Associated 42 0.373
131
ADL096 Adult Hepatocellular Carcinoma 60 0.373
132
DST001 Distal Biliary Tract Carcinoma 24 0.373
133
MTN001 Metanephric Adenoma 39 0.373
134
LNG012 Lung Occult Squamous Cell Carcinoma 20 0.373
135
LBL001 Lobular Neoplasia 55 0.373
136
P LPS002 Liposarcoma 64 0.373
137
c PRG047 Progressive Familial Intrahepatic Cholestasis 64 0.373
138
PDT042 Pediatric Hepatocellular Carcinoma 50 0.373
139
PTY007 Pityriasis Rotunda 26 0.373
140
MLT003 Multilocular Clear Cell Renal Cell Carcinoma 32 0.373
141
CLR030 Clear Cell Renal Cell Carcinoma 54 0.373
142
CRV013 Cervical Adenoid Cystic Carcinoma 33 0.373
143
FBR086 Fibrolamellar Carcinoma 59 0.373
144
HPT011 Hepatocellular Clear Cell Carcinoma 45 0.373
145
MCP006 Mucoepidermoid Carcinoma 48 0.373
146
OVR062 Ovary Serous Adenocarcinoma 25 0.373
147
LNG007 Lung Mixed Small Cell and Squamous Cell Carcinoma 20 0.373
148
PRM126 Primary Peritoneal Carcinoma 61 0.373
149
MLT165 Multilocular Cystic Renal Neoplasm of Low Malignant Potential 28 0.373
150
c RTN041 Retinitis Pigmentosa 11 43 0.348
151
c OPT051 Opitz Gbbb Syndrome, Type I 45 0.348
152
P NRB001 Neuroblastoma 66 0.348
153
FRY006 Fryns Microphthalmia Syndrome 52 0.311
154
P ADL017 Adult T-Cell Leukemia 54 0.311
155
CLF027 Cleft Palate, Isolated 64 0.311
156
HRT011 Heart Septal Defect 49 0.311
157
P VNT002 Ventricular Septal Defect 58 0.311
158
P PTN014 Patent Ductus Arteriosus 1 59 0.311
159
TCL001 T-Cell Adult Acute Lymphocytic Leukemia 42 0.311
160
TCL028 T-Cell Lymphoblastic Leukemia/lymphoma 46 0.311
161
c LKM005 Leukemia, T-Cell, Chronic 33 0.311
162
P MCR010 Microcephaly 59 0.220
163
P RCT021 Rectum Cancer 54 0.220
164
P RTN024 Retinoblastoma 72 0.156
165
YMN001 Yemenite Deaf-Blind Hypopigmentation Syndrome 66 0.156
166
HLX001 Helix Syndrome 47 0.156
167
ATS010 Autosomal Recessive Disease 42 0.156
168
DFF005 Diffuse Large B-Cell Lymphoma 55 0.156
169
LWG006 Low Grade Glioma 41 0.156
170
P MDL005 Medulloblastoma 75 0.156
171
P MLN069 Melanoma, Uveal 59 0.156
172
CLB010 Coloboma of Macula 53 0.156
173
TMT003 Temtamy Syndrome 37 0.156
174
BRN032 Brain Glioma 45 0.156
175
UTR056 Uterine Corpus Endometrial Carcinoma 27 0.156
176
END075 Endocervical Adenocarcinoma 37 0.156
177
JVN004 Juvenile Myelomonocytic Leukemia 67 0.156
178
P KBK002 Kabuki Syndrome 1 66 0.156
179
c SML038 Small Cell Cancer of the Lung 69 0.156
180
CHL065 Cholangiocarcinoma 58 0.156
181
P CHR285 Chronic Myelomonocytic Leukemia 59 0.156
182
CRB138 Core Binding Factor Acute Myeloid Leukemia 44 0.156
183
GLB002 Glioblastoma 67 0.156
184
P ADN016 Adenocarcinoma 63 0.156
185
INT079 Intrahepatic Cholangiocarcinoma 51 0.156
186
P RTN018 Retinal Disease 53 0.156
187
MYL031 Myeloproliferative Neoplasm 66 0.156
188
PNC129 Pancreatic Adenocarcinoma 65 0.156
189
BLD131 Bladder Urothelial Carcinoma 59 0.156
190
CRV038 Cervical Squamous Cell Carcinoma 56 0.156
191
SPP011 Suppression of Tumorigenicity 12 61 0.156
192
CYT019 Cytogenetically Normal Acute Myeloid Leukemia 30 0.156
193
P SZR006 Seizure Disorder 69 0.156
194
CRC021 Carcinosarcoma 62 0.156
195
SKN019 Skin Melanoma 70 0.156
196
P BCL017 B-Cell Lymphoma 57 0.156
197
THY029 Thyroid Carcinoma 54 0.156
Content
Loading form....